We are live on ! Find out more
VCYT icon

Veracyte

195 hedge funds and large institutions have $1.37B invested in Veracyte in 2019 Q2 according to their latest regulatory filings, with 63 funds opening new positions, 71 increasing their positions, 50 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more first-time investments, than exits

New positions opened: 63 | Existing positions closed: 14

42% more repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 50

39% more capital invested

Capital invested by funds: $983M → $1.37B (+$385M)

31% more funds holding

Funds holding: 149195 (+46)

4.45% more ownership

Funds ownership: 95.54%99.99% (+4.5%)

0% more funds holding in top 10

Funds holding in top 10: 77 (0)

2% less call options, than puts

Call options by funds: $2.08M | Put options by funds: $2.12M

Holders
195
Holders Change
+46
Holders Change %
+30.87%
% of All Funds
4.24%
Holding in Top 10
7
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.15%
New
63
Increased
71
Reduced
50
Closed
14
Calls
$2.08M
Puts
$2.12M
Net Calls
-$39K
Net Calls Change
+$1.11M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$114M +$30.4M +1,215,062 +44%
GGHC
2
Gilder Gagnon Howe & Co
New York
$110M +$10.4M +418,227 +12%
AIM
3
ARK Investment Management
Florida
$86.6M -$10.6M -422,420 -12%
Invesco
4
Invesco
Georgia
$85.1M +$59.7M +2,390,394 +402%
VVM
5
Versant Venture Management
California
$68.7M -$30.1M -1,205,406 -33%
Vanguard Group
6
Vanguard Group
Pennsylvania
$65.5M +$15.4M +618,054 +37%
NAMA
7
Nikko Asset Management Americas
New York
$61.2M +$38.4M +1,539,114 +253%
State Street
8
State Street
Massachusetts
$54.8M +$19.8M +792,845 +70%
N
9
Nuveen
North Carolina
$33.5M +$29.4M +1,175,197 New
Sumitomo Mitsui Trust Group
10
Sumitomo Mitsui Trust Group
Japan
$32.2M +$13.3M +534,049 +89%
EAM
11
Eventide Asset Management
Massachusetts
$26.5M
Fiera Capital (Canada)
12
Fiera Capital (Canada)
Quebec, Canada
$26.2M +$18.9M +754,988 +463%
Prudential Financial
13
Prudential Financial
New Jersey
$22.1M +$9.12M +365,015 +89%
NCGI
14
Next Century Growth Investors
Minnesota
$21.5M +$691K +27,677 +4%
William Blair Investment Management
15
William Blair Investment Management
Illinois
$20.7M +$6.31M +252,540 +53%
Goldman Sachs
16
Goldman Sachs
New York
$20.7M -$5.04M -201,920 -22%
BAMCO Inc
17
BAMCO Inc
New York
$19.1M +$16.8M +671,239 New
FLAM
18
First Light Asset Management
Minnesota
$16.8M -$4.58M -183,480 -24%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$16.4M +$3.19M +127,555 +29%
Millennium Management
20
Millennium Management
New York
$15.8M -$6.59M -263,804 -32%
Renaissance Technologies
21
Renaissance Technologies
New York
$15M +$1.77M +70,700 +16%
Deutsche Bank
22
Deutsche Bank
Germany
$14.3M +$6.17M +246,820 +97%
Allianz Asset Management
23
Allianz Asset Management
Germany
$14.2M -$2.05M -82,192 -14%
ACP
24
Acuta Capital Partners
California
$13.7M +$2.5M +100,000 +26%
Robeco Institutional Asset Management
25
Robeco Institutional Asset Management
Netherlands
$13.3M +$6.52M +260,870 +127%

VCYT Hedge Fund Activity: Q2 2019 in Review

195 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q2 2019, worth a combined $1.37B — up 39% from $983M a quarter earlier.

Buyers outnumbered sellers: 63 funds opened new VCYT positions and 14 closed out — a net gain of 49 holders — while 71 added to existing stakes and 50 trimmed.

The largest buyer was Invesco, adding an estimated $59.7M. The largest seller was Versant Venture Management, cutting an estimated $30.1M.

  • 195 institutional investors held Veracyte (VCYT) as of Q2 2019, up from 149 in Q1 2019.
  • Funds reported $1.37B of Veracyte stock for Q2 2019, up 39% quarter-over-quarter.
  • 63 funds opened new Veracyte positions in Q2 2019 and 14 closed out, a net change of +49 holders.
  • The largest Veracyte buyer in Q2 2019 was Invesco, an estimated $59.7M added.
  • The largest Veracyte seller in Q2 2019 was Versant Venture Management, an estimated $30.1M sold.

Based on aggregated 13F filings for Q2 2019.